Dermatology
Latest News
Contact allergens lurk in diabetes devices
Some reports suggest that at any given time, skin complications may affect as many as one quarter to one half of patients who use diabetes devices...
Latest News
Beware the hidden allergens in nutritional supplements
A detailed history of supplement use is important, as it may reveal possible allergens as the cause of previously unidentified reactions.
Latest News
Controlled hyperthermia: Novel treatment of BCCs without surgery continues to be refined
A novel, noninvasive technique of controlled hyperthermia and mapping protocol designed to help clinicians with margin assessment and treatment of...
Latest News
COVID-19 and psoriasis: Is there a link?
“Infection with COVID-19 has been associated with flares of guttate and pustular psoriasis, and even psoriasis that affects 100% of the skin.”
Latest News
FDA puts partial hold on investigational alopecia areata drug deuruxolitinib
The announcement came after a pulmonary embolism occurred with the 12-mg twice-daily dose in one of the long-term open-label extension studies.
Latest News
Gray hair and aging: Could ‘stuck’ stem cells be to blame?
New evidence points to a cycle wherein undifferentiated stem cells mature to perform their hair-coloring duties and then transform back to their...
Conference Coverage
Meta-analysis examines cancer risk concern for JAK inhibitors
Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than...
Latest News
Small study finds IPL-radiofrequency combination effective for dry eye disease
In the study of 11 patients, meibomian gland expression and meibum quality improved in all eyelids after treatment.
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
From the Journals
Study focuses on adolescent data in upadacitinib AD trials
Upadacitinib was generally well tolerated among the adolescents, with mild or moderate acne being the most common adverse event.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...